Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Rivory

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Urology|December 1, 1990
Evaluation of a bladder advancement extension graft techniqueR A Gardiner, G A Mills, L P Rivory, et al.
Clinical Pharmacokinetics|May 1, 2001
The erythromycin breath test for the prediction of drug clearanceL P Rivory, K A Slaviero, J M Hoskins, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasmaJ M Hoskins, A S Gross, G M Shenfield, et al.
Biochemical Pharmacology|February 18, 1992
Aging and the response of the isolated perfused rat liver to vasoactive drugsD Le Couteur, L P Rivory, M S Roberts, et al.
The American Journal of Physiology|September 14, 1999
Carbon monoxide disposition in the perfused rat liverD G le Couteur, Z L Yin, L P Rivory, et al.
Pharmacology & Toxicology|January 5, 2001
Hepatic disposition of neurotoxins and pesticidesM C Yang, A J McLean, L P Rivory, et al.
The Japanese Journal of Physiology|January 6, 2005
Wash-in methodology and modeling to determine hepatocellular D-glucose transport in the perfused rat liverD G Le Couteur, Z L Yin, A J McLean, et al.
Anti-Cancer Drugs|August 7, 2001
Toxicity of irinotecan (CPT-11) and hepato-renal dysfunctionS Y Ong, S J Clarke, J Bishop, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38H M Dodds, M C Haaz, J F Riou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Urology|December 1, 1990
Evaluation of a bladder advancement extension graft techniqueR A Gardiner, G A Mills, L P Rivory, et al.
Clinical Pharmacokinetics|May 1, 2001
The erythromycin breath test for the prediction of drug clearanceL P Rivory, K A Slaviero, J M Hoskins, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasmaJ M Hoskins, A S Gross, G M Shenfield, et al.
Biochemical Pharmacology|February 18, 1992
Aging and the response of the isolated perfused rat liver to vasoactive drugsD Le Couteur, L P Rivory, M S Roberts, et al.
The American Journal of Physiology|September 14, 1999
Carbon monoxide disposition in the perfused rat liverD G le Couteur, Z L Yin, L P Rivory, et al.
Pharmacology & Toxicology|January 5, 2001
Hepatic disposition of neurotoxins and pesticidesM C Yang, A J McLean, L P Rivory, et al.
The Japanese Journal of Physiology|January 6, 2005
Wash-in methodology and modeling to determine hepatocellular D-glucose transport in the perfused rat liverD G Le Couteur, Z L Yin, A J McLean, et al.
Anti-Cancer Drugs|August 7, 2001
Toxicity of irinotecan (CPT-11) and hepato-renal dysfunctionS Y Ong, S J Clarke, J Bishop, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38H M Dodds, M C Haaz, J F Riou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
Pageof 5